Biotech and Life Sciences, M&A/Exit Deals, Quebec
Novo Nordisk to acquire Inversago Pharma for up to US $1.1B
Biotech and Life Sciences, M&A/Exit Deals, Quebec
Venture Capital Deals, Quebec, IT and Telecom, Real Estate
Public Deals, M&A/Exit Deals, Consumer Products and Services, Quebec
Venture Capital Deals, Business Products and Services, Quebec, IT and Telecom
HealthCare, M&A/Exit Deals, Quebec, IT and Telecom
Private Equity Deals, Public Deals, CleanTech, Quebec, Transportation and Logistics
Private Equity Deals, Quebec, Industrial and Manufacturing
Private Equity Deals, M&A/Exit Deals, Quebec, IT and Telecom, Media and Entertainment, United States
Private Equity Deals, Biotech and Life Sciences, Quebec, United States
Venture Capital Deals, CleanTech, Quebec, IT and Telecom
VC Funds, PE Funds, Private Deals, Quebec, Asset Management Firms
Venture Capital Deals, Biotech and Life Sciences, Quebec
Private Deals, Infrastructure Deals, Quebec, Industrial and Manufacturing, Transportation and Logistics